LTI-03
LTI-03-1002
Phase 1 small_molecule completed
Quick answer
LTI-03 for Idiopathic Pulmonary Fibrosis is a Phase 1 program (small_molecule) at Rein Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Rein Therapeutics
- Indication
- Idiopathic Pulmonary Fibrosis
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed